Pharmacology

What happens when a patient with multiple sclerosis (MS) who is clinically stable stops taking their medication? An international, multi-site study found almost 40 percent of patients had some…

A new study shows an "alarming rise" in the costs of drugs used to slow the progression of multiple sclerosis (MS) or reduce the frequency of attacks over the last 20 years. Yet this increase…

Researchers have identified a single, simple metric to guide antibiotic dosing that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens. A…

The introduction of abuse-deterrent OxyContin, coupled with the removal of propoxyphene from the US prescription marketplace, are getting the credit for decreasing opioid prescribing and overdoses in…

A Phase IIa placebo-controlled clinical trial of TOPOFEN, a topical anti-migraine therapy for moderate and severe migraine sufferers, showed that the application of a well-known non-steroidal anti-…

The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according…

Increasingly, the public distrusts science and medicine. Much of the reason has been due to lawsuits, some of it has been due to strange beliefs among wealthy elites in well-defined parts of the…

Rapid treatment with a new anti-inflammatory called C5aR could have a major impact on recovery from spinal cord injury. University of Queensland School of Biomedical Sciences researchers Dr. Marc…

Daily consumption of capsaicin, the active compound of chilli peppers, was found to have beneficial effects on liver damage. The study found capsaicin reduced the activation of hepatic stellate cells…

Today the New York Times published an op-ed by Newt Gingrich where he calls for doubling the budget for the National Institutes of Health here in the US.  Who can argue with that? Mr. Gingrich…